Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2006-04-21 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: TARASCON (13150), Bouches-du-Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA CONDAMINE : revenue, balance sheet and financial ratios
PHARMACIE DE LA CONDAMINE is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in TARASCON (13150),
this company of category PME
shows in 2024 a net income positive of 450 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA CONDAMINE (SIREN 489780627)
Indicator
2024
2023
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
450 259 €
319 571 €
407 148 €
343 270 €
304 603 €
283 685 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE LA CONDAMINE generates positive net income of 450 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 284 k€ -> 450 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
450 259 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 125%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
125.039%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
36.995%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA CONDAMINE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2023
2024
Debt ratio
20.374
144.473
89.849
67.07
24.01
125.039
Financial autonomy
72.457
35.489
47.1
54.086
67.815
36.995
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
125.042024
2019
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average+31 pts over 3 years
In 2024, the debt ratio of PHARMACIE DE LA CONDAMINE (125.04) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
36.99%2024
2019
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average-32 pts over 3 years
In 2024, the financial autonomy of PHARMACIE DE LA CONDAMINE (37.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 326.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
326.503
Liquidity indicators evolution PHARMACIE DE LA CONDAMINE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2023
2024
Liquidity ratio
235.759
273.292
372.497
506.057
362.006
326.503
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
326.52024
2019
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of PHARMACIE DE LA CONDAMINE (326.50) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE DE LA CONDAMINE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA CONDAMINE is estimated at
6 285 948 €
(range 4 377 435€ - 9 404 138€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
4377k€6285k€9404k€
6 285 948 €Range: 4 377 435€ - 9 404 138€
NAF 5 année 2024
Valuation method used
Net Income Multiple
450 259 €
×
14.0x
=6 285 949 €
Range: 4 377 435€ - 9 404 139€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA CONDAMINE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA CONDAMINE
What is the revenue of PHARMACIE DE LA CONDAMINE ?
The revenue of PHARMACIE DE LA CONDAMINE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE LA CONDAMINE profitable?
Yes, PHARMACIE DE LA CONDAMINE generated a net profit of 450 k€ in 2024.
Where is the headquarters of PHARMACIE DE LA CONDAMINE ?
The headquarters of PHARMACIE DE LA CONDAMINE is located in TARASCON (13150), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE DE LA CONDAMINE ?
The tax return of PHARMACIE DE LA CONDAMINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA CONDAMINE operate?
PHARMACIE DE LA CONDAMINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart